Hyperinsulinemia and dyslipidemia can activate innate immune cells, leading to the release of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, which in turn promote endothelial dysfunction, vascular stiffness, and sodium retention—key hallmarks of hypertension [41,42]. The gene discussed is IL1B; the disease is endothelial dysfunction.